Rhenman & Partners Asset Management AB - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 156 filers reported holding CLOVIS ONCOLOGY INC in Q1 2015. The put-call ratio across all filers is 1.84 and the average weighting 0.7%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q4 2015$2,555,000
-35.4%
73,000
+69.8%
0.39%
-38.7%
Q3 2015$3,954,000
-26.0%
43,000
-29.2%
0.63%
-1.7%
Q2 2015$5,340,000
+33.2%
60,765
+12.5%
0.64%
-5.2%
Q1 2015$4,008,000
-16.2%
54,000
-36.8%
0.68%
-51.2%
Q4 2014$4,782,000
+84.9%
85,398
+49.8%
1.39%
+83.1%
Q3 2014$2,586,000
-30.6%
57,000
-36.7%
0.76%
-31.6%
Q2 2014$3,727,00090,0001.11%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q1 2015
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 150,000$1,564,0004.60%
Healthcare Value Capital, LLC 100,000$1,043,0003.07%
Palo Alto Investors LP 5,056,286$52,712,0002.90%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,328,200$13,848,0001.53%
Ikarian Capital, LLC 513,700$5,355,0000.87%
Pinz Capital Management, LP 207,800$2,166,0000.79%
Leap Investments LP 146,300$1,525,0000.72%
Elk Creek Partners, LLC 574,616$5,990,0000.69%
SECTOR GAMMA AS 408,625$4,260,0000.68%
Artal Group S.A. 1,000,000$10,425,0000.40%
View complete list of CLOVIS ONCOLOGY INC shareholders